CD4 Counts and Life Insurance with HIV

Phillip ChinPublished on June 6, 2026 last updated on August 5, 2026

Written by Phillip Chin · Licensed Insurance Broker · NPN 8895251 · About Phillip
Updated August 5, 2026

How Your CD4 Count Affects Life Insurance With HIV

Written and verified by Phillip Chin · NPN #8895251 · Updated July 2026

The short version

Your CD4 count is the second most important metric life insurance underwriters evaluate after viral load. It measures immune system function. A count above 500 is favorable; between 350 and 500 is workable at most HIV-friendly carriers; below 350 creates significant challenges. Below 200 corresponds to the clinical AIDS threshold and dramatically limits options.

CD4 count tells underwriters how well your immune system is functioning. Combined with viral load, it gives the most complete picture of how well your HIV is controlled.

What your CD4 count means to insurers

CD4 T-cells are white blood cells that play a central role in the immune response. HIV attacks and destroys CD4 cells over time; effective ART prevents this destruction and allows CD4 counts to recover. A CD4 count measures the number of these cells per cubic milliliter of blood (cells/mL).

In a person without HIV, CD4 counts typically range from 500 to 1,500 cells/mL. For life insurance underwriters evaluating an HIV-positive applicant, the CD4 count serves as a direct measure of immune system health. A higher count indicates a healthier immune system better able to fight infections. A lower count indicates immune compromise and heightened risk of opportunistic infections—which directly affects mortality risk.

Unlike viral load, which measures the virus directly, CD4 count measures the body’s immune response to HIV and its treatment. Both metrics are necessary for a complete underwriting picture. An applicant could theoretically have a low viral load but a slow CD4 recovery; the underwriter evaluates both.

CD4 above 500 is the sweet spot — that’s where the best offers come from. Between 350 and 500, you can still qualify at multiple carriers but may face a table rating. Below 350 is where options narrow significantly. Know your number before you apply so you can set realistic expectations about which carriers are in reach.

The CD4 thresholds carriers use

Most carriers that accept HIV-positive applicants use CD4 count thresholds to establish eligibility and rating levels. While specific thresholds vary by carrier, these are the general patterns across the industry:

CD4 count	Immune status	Underwriting outcome (general)
Above 700 cells/mL	Strong immune function	Best available ratings. Approaches standard applicant territory at HIV-friendly carriers.
500–699 cells/mL	Normal to strong	Favorable. Table A to Table B typical at HIV-friendly carriers.
350–499 cells/mL	Mild immune compromise	Acceptable at many carriers. Table B to Table D depending on other factors.
200–349 cells/mL	Moderate immune compromise	Limited carrier options. Higher table ratings or decline at many carriers.
Below 200 cells/mL	Severe immune compromise (AIDS threshold)	Traditional coverage typically not available. Guaranteed issue may apply.

*Carrier thresholds vary. These represent general industry patterns, not any specific carrier’s written guidelines.

CD4 count together with viral load

No underwriter evaluates CD4 count in isolation. It is always read alongside viral load, treatment history, and the overall health profile. The combination tells a more complete story than either metric alone.

Favorable combinations

Undetectable VL + CD4 above 500: strong position
Undetectable VL + CD4 350–500 + stable trend: workable
Low VL + rising CD4 trend + long treatment history
All metrics improving year over year

Challenging combinations

Undetectable VL + CD4 below 350: limits options despite good VL
Detectable VL + any CD4: traditional coverage generally unavailable
CD4 declining despite good VL: raises questions about immune reconstitution
CD4 below 200 at any point in recent history

A common misconception is that an undetectable viral load alone is enough to guarantee favorable underwriting. It is not. Some applicants have chronically low CD4 counts even with undetectable viral load—a phenomenon sometimes called “immunological non-response.” Underwriters evaluate this as a distinct risk factor even when viral load is controlled.

Why the trend in your CD4 count matters

Most people don’t know this: carriers look at your CD4 trend, not just your current number. A count of 450 stable for three years reads very differently than one that dropped from 750 to 450 over the same period. The trend tells the underwriter whether the disease is progressing. A stable trend — even if the number isn’t ideal — is a meaningful positive.

Underwriters look at more than a single CD4 number. They look at the history of your CD4 count over time. A CD4 count of 420 cells/mL means something different depending on the direction it is heading:

Rising trend: A CD4 count that has increased from 250 to 420 over two years while on ART tells a positive story. The immune system is recovering. The trajectory is favorable.

Stable trend: A CD4 count that has remained consistently in the 400 to 450 range for three years, without declining, is reassuring. Stability suggests the current ART regimen is maintaining immune function effectively.

Declining trend: A CD4 count that has decreased from 600 to 420 over two years, even with a currently undetectable viral load, is a red flag. It may indicate emerging drug resistance, immune system issues beyond viral control, or other health concerns. Underwriters will probe this carefully.

Your lab history over multiple years tells the underwriter which of these stories applies to you. This is another reason why consistent lab monitoring—on schedule, documented with your HIV specialist—creates a stronger underwriting profile than sporadic testing.

Timing your application when your CD4 is at a seasonal low can affect your offer. CD4 counts fluctuate with illness, stress, and even time of day. If your count has been variable, discuss timing with your broker before applying. Applying right after a recent illness may produce a reading that doesn’t reflect your typical level.

Options when your CD4 count is low

If your CD4 count is below the thresholds most carriers require, traditional life insurance is more difficult to obtain. Here is an honest picture of what is available:

Below 350 cells/mL: Traditional term and whole life coverage is limited. A small number of carriers with HIV-specific programs may still consider applications at this level, particularly if viral load is undetectable and the count is trending upward. These are specialty situations that require a specialist broker with knowledge of current carrier guidelines. Do not assume a decline without expert consultation.

Below 200 cells/mL (AIDS threshold): Traditional coverage is not available at most carriers. Guaranteed issue life insurance remains available regardless of CD4 count, as it asks no health questions. Employer group life insurance, if available, typically has no health requirements. These are the primary options at this stage.

The most important path forward is working with your HIV specialist to understand why your CD4 count is low and what can be done to improve it. CD4 recovery varies; some people on effective ART see robust CD4 increases, while others recover more slowly. Your specialist can advise on treatment optimization, and improvement in CD4 count over time can eventually open the door to better underwriting outcomes.

How to improve your CD4 position

CD4 count improvement is primarily driven by effective, consistent ART use. Here are the factors that most directly support CD4 recovery:

Consistent ART adherence: Missing doses allows viral replication that damages CD4 cells. Daily adherence is the single most important factor in CD4 maintenance and recovery.
Early ART initiation: CD4 counts are better preserved in people who start ART early after diagnosis, before significant immune compromise occurs. If you have not yet started treatment and your count is declining, this is a reason to discuss starting ART with your specialist.
Treating co-infections: Hepatitis C, CMV, and other co-infections can suppress CD4 recovery. Treating these conditions may support CD4 improvement.
General health: Nutrition, sleep, moderate exercise, and avoiding tobacco and excessive alcohol use support immune function generally, including CD4 recovery.
Time: CD4 recovery takes time, sometimes years. Patients who start ART with very low counts may not reach the 500 threshold quickly even with excellent adherence. Work with your specialist to understand your specific trajectory and realistic timeline.

Common questions about CD4 and coverage

My CD4 is 380 but my viral load is undetectable. Can I get life insurance?

Possibly, yes. A CD4 of 380 with an undetectable viral load is in the workable range at HIV-friendly carriers. You will likely not qualify for the best available rates, and your carrier options are narrower than they would be with a CD4 above 500. But this is not an automatic decline situation. A specialist broker can identify which carriers to approach and what rating to expect.

Does a nadir (lowest ever) CD4 count affect underwriting?

Yes. Carriers typically ask about your lowest-ever CD4 count, and a very low historical nadir can be a complicating factor even if your current count is healthy. A nadir below 200—meaning you have been in AIDS-defining territory at some point—is a significant underwriting concern even if your current count has recovered. Disclose your history accurately; it will appear in your medical records.

How recent does my CD4 test need to be?

Carriers generally want a CD4 result within the past three to six months. Older results may be reviewed as part of your history but a current result is needed to proceed with underwriting. Schedule a lab appointment before submitting an application to ensure your most recent numbers are documented and recent.

My CD4 has been stable at 320 for years. Does stability help?

Stability is viewed more favorably than a declining count at the same level. A long-term stable CD4 at 320, alongside a consistently undetectable viral load, indicates that your HIV is under effective control even if immune reconstitution has been limited. Some carriers will consider this profile at smaller face amounts. A specialist broker can identify which ones.

Written and reviewed by Phillip Chin

Licensed Insurance Broker · NPN #8895251. Phillip is an independent broker who specializes in life insurance for people living with HIV, comparing the carriers that actually approve HIV-positive applicants.

Get a read on your underwriting position

Tell me your CD4, viral load, and how long you have been on treatment, and I will give you an honest assessment of your current options.

Get my options

Educational information from LifeInsuranceHIV.com, an independent brokerage. All coverage is subject to carrier underwriting and approval; eligibility, rates, and availability vary by carrier, state, and individual circumstances. Figures are estimates, not guarantees or offers of coverage.